Army Tests Ebola Vaccine Candidate With Yisheng Biopharma’s PIKA Adjuvant in Mice
The U.S. Army has begun preclinical trials of its vaccine candidate against Ebola virus in combination with the PIKA adjuvant platform developed by China-based Yisheng Biopharma. Study results show that mice that received a combination of the Army Medical Research Institute of Infectious Diseases’ virus-like particle-based vaccine and Yisheng’s PIKA adjuvant platform demonstrated 100 percent […] More